AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane
Open Access
- 11 December 2024
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 52, 102240
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progressionCancer Letters, 2022
- CD47: Beyond an immune checkpoint in cancer treatmentBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophagesBiomaterials, 2021
- Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2020
- Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)WIREs RNA, 2020
- CD47: role in the immune system and application to cancer therapyCellular Oncology, 2019
- HDAC6 Suppresses Let‐7i‐5p to Elicit TSP1/CD47‐Mediated Anti‐Tumorigenesis and Phagocytosis of Hepatocellular CarcinomaHepatology, 2019
- Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier StagePathology and Oncology Research, 2019
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid PhagocytosisCell, 2009
- Regulators of fetal liver differentiation in vitroArchives of Biochemistry and Biophysics, 1988